DK1519746T3 - Anvendelse af digoxin-immun Fab til regulering af natrium/kalium ATPase-aktivitet i præeklampsi/eklampsi-patienter - Google Patents
Anvendelse af digoxin-immun Fab til regulering af natrium/kalium ATPase-aktivitet i præeklampsi/eklampsi-patienterInfo
- Publication number
- DK1519746T3 DK1519746T3 DK03771818T DK03771818T DK1519746T3 DK 1519746 T3 DK1519746 T3 DK 1519746T3 DK 03771818 T DK03771818 T DK 03771818T DK 03771818 T DK03771818 T DK 03771818T DK 1519746 T3 DK1519746 T3 DK 1519746T3
- Authority
- DK
- Denmark
- Prior art keywords
- preeclampsia
- digoxin
- atpase activity
- immune fab
- potassium atpase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/202,957 US7402313B2 (en) | 2002-07-25 | 2002-07-25 | Method for controlling preeclampsia and eclampsia |
US10/292,338 US20040018202A1 (en) | 2002-07-25 | 2002-11-12 | Use of digoxin immune Fab (ovine) for the regulation of sodium/potassium ATPase activity in preeclamptic and eclamptic patients |
PCT/US2003/023235 WO2004011028A1 (en) | 2002-07-25 | 2003-07-24 | Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1519746T3 true DK1519746T3 (da) | 2009-11-02 |
Family
ID=30769950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03771818T DK1519746T3 (da) | 2002-07-25 | 2003-07-24 | Anvendelse af digoxin-immun Fab til regulering af natrium/kalium ATPase-aktivitet i præeklampsi/eklampsi-patienter |
Country Status (8)
Country | Link |
---|---|
US (2) | US7402313B2 (da) |
CN (1) | CN1688337B (da) |
DE (1) | DE60328391D1 (da) |
DK (1) | DK1519746T3 (da) |
ES (1) | ES2332781T3 (da) |
HK (1) | HK1075838A1 (da) |
NO (1) | NO20140969L (da) |
ZA (1) | ZA200500732B (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7794716B2 (en) * | 2002-07-25 | 2010-09-14 | Glenveigh Pharmaceuticals, Llc | Antibody composition and passive immunization against pregnancy-induced hypertension |
WO2005110462A2 (en) | 2004-05-04 | 2005-11-24 | Children's Medical Center Corporation | Methods and compositions for treatment of preeclampsia |
US8038997B2 (en) * | 2005-06-27 | 2011-10-18 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-marinobufagenin antibodies and methods for their use |
CN101505795B (zh) * | 2006-07-03 | 2013-02-13 | 查尔斯·戴维·阿代尔 | 用于调节细胞粘附分子表达的组合物 |
US8247492B2 (en) | 2006-11-09 | 2012-08-21 | Valspar Sourcing, Inc. | Polyester powder compositions, methods and articles |
BRPI0718527A2 (pt) * | 2006-11-09 | 2013-11-19 | Valspar Sourcing Inc | Composição em pó, método, e, artigo tridimensional |
CN103439485B (zh) * | 2013-08-22 | 2015-01-21 | 天津市康婷生物工程有限公司 | 高效检测内源性洋地黄样因子含量的试剂盒及使用方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4767720A (en) * | 1985-08-29 | 1988-08-30 | Hsc Research Development Corporation | Antidigoxin antibodies |
US5770376A (en) * | 1992-12-02 | 1998-06-23 | Biomedical Sciences Research Laboratories, Inc. | Method of diagnosing and treating myocardial infarction and hypertension |
US6290657B1 (en) * | 1998-12-16 | 2001-09-18 | Reproductive Health Technologies, Inc. | Prenatal uterine monitoring and trending system |
AU3489300A (en) * | 1999-02-12 | 2000-08-29 | University Of Louisville Research Foundation, Inc. | Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods |
CA2273699A1 (en) * | 1999-06-03 | 2000-12-03 | Sergei N. Orlov | New uses of oubain and oubain-like molecules in apoptosis related pathologies |
US7045674B2 (en) * | 2002-09-19 | 2006-05-16 | University Of Iowa Research Foundation | Animal model for preeclampsia |
WO2004071273A2 (en) | 2003-02-04 | 2004-08-26 | The Administrators Of The Tulane Educational Fund | Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus |
-
2002
- 2002-07-25 US US10/202,957 patent/US7402313B2/en not_active Expired - Lifetime
- 2002-11-12 US US10/292,338 patent/US20040018202A1/en not_active Abandoned
-
2003
- 2003-07-24 CN CN038178591A patent/CN1688337B/zh not_active Expired - Fee Related
- 2003-07-24 DE DE60328391T patent/DE60328391D1/de not_active Expired - Lifetime
- 2003-07-24 DK DK03771818T patent/DK1519746T3/da active
- 2003-07-24 ES ES03771818T patent/ES2332781T3/es not_active Expired - Lifetime
-
2005
- 2005-09-14 HK HK05108036.4A patent/HK1075838A1/xx not_active IP Right Cessation
-
2006
- 2006-01-25 ZA ZA200500732A patent/ZA200500732B/xx unknown
-
2014
- 2014-08-07 NO NO20140969A patent/NO20140969L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE60328391D1 (de) | 2009-08-27 |
HK1075838A1 (en) | 2005-12-30 |
ES2332781T3 (es) | 2010-02-12 |
US20040018202A1 (en) | 2004-01-29 |
NO20140969L (no) | 2005-04-12 |
CN1688337A (zh) | 2005-10-26 |
US20040018201A1 (en) | 2004-01-29 |
CN1688337B (zh) | 2012-06-13 |
ZA200500732B (en) | 2006-03-29 |
US7402313B2 (en) | 2008-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1485127T3 (da) | Anvendelse af midler til behandling af inflammation | |
FR19C1053I2 (fr) | Inhibiteurs de co-transporteur 2 de sodium glucose et procedes d'utilisation de ceux-ci | |
DE60324178D1 (de) | THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN | |
LTPA2017004I1 (lt) | Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai | |
DK1944322T3 (da) | Behandling af TNFalfa-relaterede sygdomme | |
IS8913A (is) | Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk | |
DE60323810D1 (de) | Bequem Windel | |
DK1673104T3 (da) | Fremføring af terapeutiske forbindelser til hjernen og andre væv | |
DK1885380T3 (da) | Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme | |
DK1523489T3 (da) | Modificerede 2'- og 3'-nukleosidprodrugs til behandling af flaviridae-infektioner | |
DK2041129T3 (da) | Inhibitorer af human proteintyrosinphosphatase og deres farmaceutiske anvendelse | |
DK3279663T3 (da) | Anvendelse af gelsolin til diagnosticering og behandling af inflammationssygdomme | |
IS7851A (is) | 1-asýl-pýrrólídínafleiður til að meðhöndla veirusýkingar | |
DK2114419T3 (da) | Natriummetaarsenit til anvendelse i behandling af smerte og inflammation | |
DE60104978D1 (de) | Selektive kristallisierung von 3-pyridyl-1-hydroxyethyliden-1,1-bisphosphonsäure natrium als hemipentahydrat oder monohydrat | |
FI20021262A (fi) | Sokerien kiteytys | |
DE60319997D1 (de) | Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium | |
FR2873585B1 (fr) | Nouvelles formulations galeniques de principes actifs | |
DK1519746T3 (da) | Anvendelse af digoxin-immun Fab til regulering af natrium/kalium ATPase-aktivitet i præeklampsi/eklampsi-patienter | |
DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
ATE372113T1 (de) | Aminoalkoxyindol-derivate als 5-ht6- rezeptorliganden zur bekämpfung von zns- krankheiten | |
DK1503747T3 (da) | Diclofenacbaseret sammensætning til topisk behandling af sygdomme | |
DK1350838T3 (da) | Ekspression af rekombinante humane proteiner i tetrahymena | |
ATE325115T1 (de) | Pyrimidinderivate als selektive cox-2-inhibitoren | |
DK1617876T3 (da) | Thorium-227 til anvendelse i strålebehandling af bløddels-sygdomme |